This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year
The company recorded its quarterly consolidated revenue from operations at Rs. 61.22 crore in Q4 FY25
The company has posted net profit of Rs. 40.88 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
Global Health has posted net profit of Rs. 481.43 crores for the Financial Year ended March 31, 2025
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
The company has posted net profit of Rs. 30.53 crores for the Financial Year ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
